Sage Products, Inc.   Report issue

For profit Phase 3
Founded: Hebron IL United States (1971)
Status: Acquired by Stryker (2016)

Organization Overview

First Clinical Trial
2005
NCT00130221
First Marketed Drug
2005
chlorhexidine (hibitane)
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

SAGE CHEMS | SAGE PRODS | Sage Products, Inc.

Active Ingredients

Marketed Drugs (2)

apomorphine (apokyn) (2022)

chlorhexidine (hibitane) (2005)

Drugs in Phase 3 Trials (1)

chlorhexidine (hibitane) (7 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacteremia (Phase 1)

Clostridium Infections (Phase 1)

Communicable Diseases (Phase 3)

Cross Infection (Phase 3)

Infections (Phase 3)

Pneumonia (Phase 1)

Postoperative Complications (Phase 3)

Surgical Wound Infection (Phase 3)

Urinary Tract Infections (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 1